CMR advances surgical robotics training with French initiative
CMR Surgical in Cambridge, which invented the Versius robotics arm for keyhole operations, has strengthened its position as pathfinder in the field with a globally significant alliance.
It has partnered with IRCAD, a world-renowned research and training centre for laparoscopic and robotic surgical training, based in Strasbourg.
For the first time, the Versius® Surgical Robotic System will be used for surgical training at IRCAD, which specialises in all specialties of minimally invasive surgery from its French headquarters.
With more than 6,200 surgeons participating in training at IRCAD each year, this partnership opens the door for many more to have the opportunity to develop skills in robotic minimal access surgery and gain valuable hands-on experience of Versius.
Professor Jacques Marescaux, President and founder of IRCAD, said: “As the surgical robotics market continues to grow, IRCAD has evolved to provide a comprehensive robotics training programme.
“We are excited to be able to integrate the unique technology and digital capabilities of Versius into this programme and look forward to a strong partnership with CMR moving forwards as robotics becomes increasingly important in cancer surgery.”
While manual MAS is complex to perform, the benefits for patients are well recognised. As a next-generation surgical robot, Versius has been designed to bridge this gap.
Working alongside IRCAD, CMR is committed to standardising training to ensure the safe introduction of robotic surgery worldwide.
Mark Slack, chief medical officer for CMR Surgical said: “We see this training partnership as an important opportunity to bring the benefits of MAS to more patients around the world.
“With surgical robotics increasingly becoming integrated into operating theatres, we have a responsibility to ensure optimal training of surgeons and surgical teams.
“The use of Versius within IRCAD will not only support best practice but add important data to our clinical registry – allowing us to use data-driven insights to further improve patient care.”